Prophylactic laser versus continued surveillance after initial bevacizumab treatment for retinopathy of prematurity-Reference-Cited by-同舟云学术

Prophylactic laser versus continued surveillance after initial bevacizumab treatment for retinopathy of prematurity

Published:2021-06 Issue:3 Volume:25 Page:177-180
ISSN:1091-8531
Container-title:Journal of American Association for Pediatric Ophthalmology and Strabismus
language:en
Short-container-title:Journal of American Association for Pediatric Ophthalmology and Strabismus

Author:

Hong Gloria J.,Stinnett Sandra S.,Freedman Sharon F.,Wallace David K.,Prakalapakorn S. Grace

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Ophthalmology,Pediatrics, Perinatology and Child Health

Reference10 articles.

1. Screening Examination of Premature Infants for Retinopathy of Prematurity

2. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity;Mintz-Hittner;N Engl J Med,2011

3. Anti-vascular endothelial growth factor therapy for primary treatment of type 1 retinopathy of prematurity: a report by the American Academy of Ophthalmology;VanderVeen;Ophthalmology,2017

4. Reactivation of retinopathy of prematurity after bevacizumab injection. Arch Ophthalmol 2012;130:1000-1006;Hu;Published correction in Arch Ophthalmol,2013

5. Reactivation of retinopathy of prematurity three years after treatment with bevacizumab;Hajrasouliha;Ophthalmic Surg Lasers Imaging Retina,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global Disparities in Retinopathy of Prematurity: A Literature Review;Seminars in Ophthalmology;2022-11-30

2. Low- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity;Ophthalmology;2022-10